FI944997A0 - Förbättrad av rekombinanta proteiner produktion - Google Patents

Förbättrad av rekombinanta proteiner produktion

Info

Publication number
FI944997A0
FI944997A0 FI944997A FI944997A FI944997A0 FI 944997 A0 FI944997 A0 FI 944997A0 FI 944997 A FI944997 A FI 944997A FI 944997 A FI944997 A FI 944997A FI 944997 A0 FI944997 A0 FI 944997A0
Authority
FI
Finland
Prior art keywords
recombinant proteins
improved production
production
improved
recombinant
Prior art date
Application number
FI944997A
Other languages
English (en)
Finnish (fi)
Other versions
FI944997A (sv
Inventor
Leif Kongerslev
John Pedersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI944997A0 publication Critical patent/FI944997A0/sv
Publication of FI944997A publication Critical patent/FI944997A/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0037Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • C12N2500/25Insulin-transferrin; Insulin-transferrin-selenium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/70Undefined extracts
    • C12N2500/76Undefined extracts from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/70Undefined extracts
    • C12N2500/80Undefined extracts from animals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI944997A 1992-04-24 1994-10-24 Förbättrad av rekombinanta proteiner produktion FI944997A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK53792A DK53792D0 (da) 1992-04-24 1992-04-24 Fremgangsmaade til fremstilling af proteiner
PCT/DK1993/000138 WO1993022425A1 (en) 1992-04-24 1993-04-23 Improved recombinant protein production

Publications (2)

Publication Number Publication Date
FI944997A0 true FI944997A0 (sv) 1994-10-24
FI944997A FI944997A (sv) 1994-10-24

Family

ID=8094667

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944997A FI944997A (sv) 1992-04-24 1994-10-24 Förbättrad av rekombinanta proteiner produktion

Country Status (13)

Country Link
US (1) US5356798A (sv)
EP (1) EP0640125A1 (sv)
JP (1) JPH07505780A (sv)
KR (1) KR950701380A (sv)
AU (1) AU4260393A (sv)
CA (1) CA2134198A1 (sv)
CZ (1) CZ261394A3 (sv)
DK (1) DK53792D0 (sv)
FI (1) FI944997A (sv)
HU (1) HUT68274A (sv)
NO (1) NO944025D0 (sv)
RU (1) RU94045945A (sv)
WO (1) WO1993022425A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
WO2002029045A2 (en) * 2000-10-02 2002-04-11 Novo Nordisk A/S Method for the production of vitamin k-dependent proteins
US20040014657A1 (en) * 2001-11-05 2004-01-22 Jan Ohrstrom Use of blood coagulation factor XIII for treating haemophilia A
KR20040039472A (ko) 2001-10-02 2004-05-10 노보 노르디스크 헬스 케어 악티엔게젤샤프트 진핵 세포에서 재조합체 단백질의 제조 방법
BR112022026594A2 (pt) * 2020-06-26 2023-04-18 Sunnybrook Res Inst Suplementos de extrato de gema para meios de cultura e métodos relacionados

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3048289A1 (de) * 1980-12-20 1982-07-29 Hoechst Ag "verfahren zur zuechtung von insektenzellen"
JPH07106156B2 (ja) * 1983-10-28 1995-11-15 ジェネティックス、インスティチュ−ト ファクタ−▲viii▼および関連生産物の製造
DE3586402T3 (de) * 1984-01-12 2004-12-23 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Proteinzusammensetzung mit Koagulations-wirkung und Verfahren zu ihrer Herstellung.
IL74909A (en) * 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
JPS6163283A (ja) * 1984-09-03 1986-04-01 Teijin Ltd ハイブリ−ド−マの培養方法
ES8801674A1 (es) * 1985-04-12 1988-02-16 Genetics Inst Un procedimiento para la preparacion de una proteina que presenta actividad procoagulante.
KR910006424B1 (ko) * 1985-08-21 1991-08-24 인코텍스 비.브이 편성브리프(brief) 제조방법
ATE87663T1 (de) * 1986-01-03 1993-04-15 Genetics Inst Verfahren zur herstellung von faktor-viii:c-typ- proteinen.
FI98829C (sv) * 1986-01-27 1997-08-25 Chiron Corp Förfarande för framställning av rekombinerat proteinkomplex med humanfaktor VIII:C aktivitet
US5451521A (en) * 1986-05-29 1995-09-19 Genetics Institute, Inc. Procoagulant proteins
EP0251843A1 (fr) * 1986-06-06 1988-01-07 Transgene S.A. Procédé de préparation de facteur VIII à partir de cellules de mammifères
EP0254076B1 (en) * 1986-07-11 1991-05-08 Miles Inc. Improved recombinant protein production
IL83192A (en) * 1986-07-18 1992-11-15 Gist Brocades Nv Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies
IL84168A0 (en) * 1986-10-15 1988-03-31 Rorer Int Overseas Human factor viii-c analogs,process for the preparation thereof and pharmaceutical compositions containing the same
US4980456A (en) * 1987-04-06 1990-12-25 Scripps Clinic And Research Foundation Recombinant factor VIIIC derived fragments
EP0690126B1 (en) * 1987-06-12 2001-11-28 Baxter Aktiengesellschaft Novel proteins with factor VIII activitiy: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
FR2619314B1 (fr) * 1987-08-11 1990-06-15 Transgene Sa Analogue du facteur viii, procede de preparation et composition pharmaceutique le contenant
ZA909167B (en) * 1989-11-17 1993-10-15 Chiron Corp Protein complexes having Factor VIII:C activity and production thereof
SE465222C5 (sv) * 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
FR2657884B1 (fr) * 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.

Also Published As

Publication number Publication date
CA2134198A1 (en) 1993-11-11
US5356798A (en) 1994-10-18
HUT68274A (en) 1995-06-28
EP0640125A1 (en) 1995-03-01
WO1993022425A1 (en) 1993-11-11
JPH07505780A (ja) 1995-06-29
DK53792D0 (da) 1992-04-24
HU9403070D0 (en) 1994-12-28
AU4260393A (en) 1993-11-29
NO944025L (no) 1994-10-21
KR950701380A (ko) 1995-03-23
CZ261394A3 (en) 1995-02-15
FI944997A (sv) 1994-10-24
RU94045945A (ru) 1997-03-27
NO944025D0 (no) 1994-10-21

Similar Documents

Publication Publication Date Title
DE69434520D1 (de) Biotinylierung von proteinen
ATA257190A (de) Virales polypeptid
DK91192D0 (da) Protein
DK97790A (da) Renin-inhiberende peptider
DK603888A (da) Rekombinant virus
KR950702242A (ko) 사포린 함유 단백질의 재조합 생산방법(Recombinant production of saporin-containing proteins)
DK132892D0 (da) Proteiner
DK353788A (da) Polypeptidderivater
DK354389D0 (da) Polypeptid
FI941749A0 (sv) Framställning av rekombinant-Borrealiaproteiner
DK0406598T3 (da) Proteinhydrolyse
DE68925304D1 (de) Minimale Derivatisierung von Proteinen
DK395288D0 (da) Proteiner
FI944997A0 (sv) Förbättrad av rekombinanta proteiner produktion
DE69120700D1 (de) Polypeptidepaar
GB9714680D0 (en) Recombinant production of proteins
DK75393D0 (da) Production of protein
DK354989D0 (da) Modificerede proteiner
GB9104596D0 (en) Production of recombinant proteins
FI951212A (sv) Framställning av beta-metylkarbapenemmellanprodukter
GB9714681D0 (en) Recombinant production of proteins
AU5462694A (en) Improved recombinant production of proteins having factor viii:c activity
KR930026760U (ko) Tvcr의 개선된 구성
DK596888A (da) Rekombinant lymfotoksin
ITRM920517A1 (it) Procedimento di produzione della proteina sv-iv ricombinante e proteina sv-iv ricombinante.

Legal Events

Date Code Title Description
FD Application lapsed